Review
Sep 2026
Pharmacological solutions for vitiligo: emerging role of Janus kinase inhibitors
Developments support the emerging role of JAK-directed therapy as a significant advancement in the management of vitiligo by enabling targeted modulation of specific inflammatory pathways central to vitiligo pathophysiology.
H. Kocic, Uwe Wollina, A. Godić et al.
· Expert Opinion on Pharmacoth... · 0 citations